Compare Boston Scientific Corporation (BSX) vs Global X CleanTech (CTEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs Global X CleanTech — how do they compare? Boston Scientific Corporation trades at $42.62 (market cap $66.37B), while Global X CleanTech trades at $56.49. The key difference: Global X CleanTech is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | CTEC | |
|---|---|---|
Market Cap | $66.37B | — |
Sector | Health | Sector/Thematic |
52-Week High | $108.14 | $78.11 |
52-Week Low | $42.63 | $39.45 |
Enterprise Value | $75.94B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CTEC trades at $57.34, down 2.88% today amid bearish technical signals, with moving averages indicating selling pressure but oscillators showing potential oversold conditions. Key financial ratios including P/E, P/S, and ROE are unavailable, limiting fundamental clarity. The company has announced a future dividend of $0.07 per share payable in July 2026, though recent earnings and cash flow data are not provided.
The outlook remains cautious due to weak technical momentum and incomplete financial disclosure. Investment opportunity hinges on upcoming financial results revealing profitability and growth, while risks include persistent selling pressure and lack of current fundamental visibility. Investors await clearer earnings updates to assess valuation and business health.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About Global X CleanTech
CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.
Read more on CTEC →
